These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13678396)

  • 21. Current perspectives on statins.
    Mishra TK; Routray S
    J Indian Med Assoc; 2003 Jun; 101(6):381-3. PubMed ID: 14579987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polyphepan (lignin) as an hypocholesteremic agent].
    Frolkis AV; Abramzon MA; Kislova GD; Levanova VP
    Klin Med (Mosk); 1987 Jul; 65(7):48-52. PubMed ID: 3312799
    [No Abstract]   [Full Text] [Related]  

  • 23. NCEP ATP III guidelines incorporate global risk assessment.
    Gotto AM;
    Am J Manag Care; 2003 Aug; Suppl():1, 3. PubMed ID: 13678394
    [No Abstract]   [Full Text] [Related]  

  • 24. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
    Weizel A; Sawicki PT
    MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
    J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
    Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholesterol and coronary sclerosis].
    Immich H
    Versicherungsmedizin; 1997 Jun; 49(3):86-8. PubMed ID: 9273772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cholesterol synthesis inhibitors. Clinical studies on lowering coronary risk and plaque stabilization].
    Müller-Wieland D; Faust M; Krone W
    Internist (Berl); 1998 Sep; 39(9):934-42. PubMed ID: 9788115
    [No Abstract]   [Full Text] [Related]  

  • 31. Apolipoproteins as markers and managers of coronary risk.
    Chan DC; Watts GF
    QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How low to target LDL?
    Robinson JG; Davidson MH
    Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):414-5. PubMed ID: 16932325
    [No Abstract]   [Full Text] [Related]  

  • 33. Adult treatment panel III and the management of dyslipidemia risk factors.
    Stein EA
    Postgrad Med; 2002 Oct; 112(4 Suppl):12-7. PubMed ID: 19667595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New trends in lipid management: eight cases to consider.
    Smith DA
    Mt Sinai J Med; 2005 Mar; 72(2):90-9. PubMed ID: 15770338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary artery disease in women.
    Banerjee AK
    Indian Heart J; 2008; 60(4):342-5. PubMed ID: 19242013
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.
    Stone NJ; Bilek S; Rosenbaum S
    Am J Cardiol; 2005 Aug; 96(4A):53E-59E. PubMed ID: 16098845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol management.
    Griffith K
    Practitioner; 2006 Sep; 250(1686):23-4, 26, 29. PubMed ID: 17036915
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on lipid-lowering therapy and LDL-cholesterol targets.
    Wiviott SD; Cannon CP
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):424-36. PubMed ID: 16874355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.